FDA Approved: FLAGYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Flagyl (metronidazole) from Pfizer Laboratories Div Pfizer Inc, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebiasis
• Anaerobic Bacterial Infection
• Bacterial Vaginosis
• Clostridioides Difficile Infection
• Giardiasis
• Gynecologic Infection
• Intra-abdominal Infection
• Trichomoniasis

Drugs mentioned

• FLAGYL (Metronidazole)

Snippet

SUPPL AP for FLAGYL (METRONIDAZOLE)